SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MIRANDOLA, Prisco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.925
EU - Europa 471
AS - Asia 354
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.925
CN - Cina 210
UA - Ucraina 130
DE - Germania 121
TR - Turchia 95
GB - Regno Unito 61
IT - Italia 49
SE - Svezia 43
SG - Singapore 37
FI - Finlandia 31
RU - Federazione Russa 17
BE - Belgio 9
FR - Francia 8
HK - Hong Kong 5
EU - Europa 3
IR - Iran 3
CZ - Repubblica Ceca 2
JP - Giappone 2
BD - Bangladesh 1
TW - Taiwan 1
Totale 2.753
Salva come PNG Salva come JPEG
Città #
Woodbridge 319
Fairfield 244
Chandler 159
Jacksonville 149
Houston 140
Seattle 110
Ann Arbor 103
Ashburn 98
Wilmington 94
Cambridge 87
Izmir 62
Nanjing 46
Beijing 33
Princeton 31
Addison 30
Boardman 26
Dearborn 26
Singapore 24
Ferrara 23
Shanghai 20
Nanchang 18
San Diego 18
Bremen 15
Milan 13
Shenyang 13
Changsha 12
Hebei 10
San Mateo 10
Brussels 9
Auburn Hills 8
Falls Church 8
Jiaxing 8
Jinan 8
Tianjin 8
Kunming 7
Los Angeles 7
New York 6
Hong Kong 5
Mountain View 5
Philadelphia 5
Chicago 4
Norwalk 4
Tappahannock 4
Zhengzhou 4
Des Moines 3
Guangzhou 3
Haikou 3
Hefei 3
Lanzhou 3
Munich 3
Redmond 3
Taizhou 3
Brno 2
Hangzhou 2
Ningbo 2
Osaka 2
Redwood City 2
Ardabil 1
Augusta 1
Chiswick 1
Hounslow 1
Indiana 1
Lappeenranta 1
Lavello 1
London 1
Monmouth Junction 1
Orange 1
Palma Campania 1
Parma 1
Shaoxing 1
Sunnyvale 1
Taipei 1
Verona 1
Totale 2.083
Salva come PNG Salva come JPEG
Nome #
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 153
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 119
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells 116
Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication 114
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 114
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 113
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 112
null 112
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 111
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 103
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 100
Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cells 98
NK-active cytokines IL-2, IL-12 and IL-15 selectively modulate specific protein kinase C (PKC) isoforms in primary human NK cells. 93
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 91
null 90
null 88
null 86
Infection of CD34+ hematopoietic progenitor cells by human herpesvirus 7 (HHV-7) 86
Stromal derived factor-1 induces apoptosis in activated primary CD4+ T cells. 84
Cytotoxic drugs regulate VEGF and IL-8 expression in human melanoma cells by A2A and A3 adenosine receptors. 77
Human herpesvirus 7 infection impairs the survival/differentiation of megakaryocytic cells 70
null 66
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 65
Growth regulation of tumor cells in hypoxia: Focus on A3 adenosine receptors. 64
Adenosine receptors as mediators of both cells proliferation and cells death of cultured human melanoma cells. 63
A3 adenosine receptors modulate hypoxia-inducible factor-1-alpha expression in human A375 melanoma cells 62
Cannabinoid CB2 receptor modulates microglial cell activation: role of ERK-1/2 Kinase signaling. 61
A3 ADENOSINE RECEPTORS MODULATE HYPOXIA-INDUCIBLE FACTOR-1ALPHA EXPRESSION IN HUMAN CANCER CELLS 60
VEGF and IL-8 regulation by cytotoxic drugs in human melanoma cells: molecular mechanism modulated by A2B and A3 adenosine receptors 60
Vascular endothelial growth factor regulation by adenosine via hypoxia-inducible factor-1 in hypoxic human glioblastoma cells. 56
Adenosine Receptors in Colon Carcinoma Tissues and Colon Tumoral Cell Lines: Focus on the A3 Adenosine Subtype 26
A2B AND A3 ADENOSINE RECEPTORS MODULATE VASCULAR ENDOTHELIAL GROWTH FACTOR AND INTERLEUKIN-8 EXPRESSION IN HUMAN MELANOMA CELLS TREATED WITH ETOPOSIDE AND DOXORUBICIN. 21
Activation of the nitric oxide synthase pathway represents a key component of the TNF-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity on hematological malignancies. 20
Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells. 17
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway 7
Receiver Operating Characteristic Analysis of Posture and Gait Parameters to Prevent Frailty Condition and Fall Risk in the Elderly 2
Totale 2.780
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020640 108 21 15 88 53 86 66 67 49 62 11 14
2020/2021368 37 50 7 55 11 39 13 43 5 36 50 22
2021/2022329 5 37 17 17 12 16 9 14 10 29 28 135
2022/2023347 35 40 10 44 74 45 11 17 39 2 21 9
2023/2024120 20 16 6 3 9 9 10 3 5 4 0 35
2024/202516 16 0 0 0 0 0 0 0 0 0 0 0
Totale 2.780